Yesterday, Nov. 24, 2015, 106 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $189.51 to $48,391,506.50.

Highlighted Stocks Traded by Insiders:

Paylocity (PCTY) - FREE Research Report

Haske Michael R, who is Senior VP of Sales & Marketing at Paylocity, sold 100,000 shares at $42.50 on Nov. 24, 2015. Following this transaction, the Senior VP of Sales & Marketing owned 1.6 million shares meaning that the stake was reduced by 5.93% with the 100,000-share transaction.

The shares most recently traded at $43.94, up $1.44, or 3.28% since the insider transaction. Historical insider transactions for Paylocity go as follows:

  • 4-Week # shares sold: 332,808
  • 12-Week # shares sold: 1.8 million
  • 24-Week # shares sold: 1.8 million

The average volume for Paylocity has been 274,900 shares per day over the past 30 days. Paylocity has a market cap of $2.2 billion and is part of the technology sector and computer software & services industry. Shares are up 67.48% year-to-date as of the close of trading on Tuesday.

Paylocity Holding Corporation provides cloud-based payroll and human capital management (HCM) software solutions for medium-sized organizations in the United States. Currently, there are 6 analysts who rate Paylocity a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on PCTY - FREE

TheStreet Quant Ratings

rates Paylocity as a

sell

. The area that we feel has been the company's primary weakness has been its feeble growth in its earnings per share. Get the full

Paylocity Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Zions Bancorp (ZION) - FREE Research Report

Laursen Thomas E, who is Sr. Vice President & at Zions Bancorp, sold 1,000 shares at $30.07 on Nov. 24, 2015. Following this transaction, the Sr. Vice President & owned 35,772 shares meaning that the stake was reduced by 2.72% with the 1,000-share transaction.

The shares most recently traded at $29.71, down $0.36, or 1.23% since the insider transaction. Historical insider transactions for Zions Bancorp go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 240,042

The average volume for Zions Bancorp has been 2.7 million shares per day over the past 30 days. Zions Bancorp has a market cap of $5.9 billion and is part of the financial sector and banking industry. Shares are up 2.1% year-to-date as of the close of trading on Wednesday.

Zions Bancorporation, a financial holding company, provides a range of banking and related services in Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming. The stock currently has a dividend yield of 0.83%. The company has a P/E ratio of 27.9. Currently, there are 9 analysts who rate Zions Bancorp a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ZION - FREE

TheStreet Quant Ratings

rates Zions Bancorp as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, expanding profit margins and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

Zions Bancorp Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Chemed (CHE) - FREE Research Report

Lee Spencer S, who is executive vice president at Chemed, sold 5,000 shares at $154.10 on Nov. 24, 2015. Following this transaction, the executive vice president owned 43,405 shares meaning that the stake was reduced by 10.33% with the 5,000-share transaction.

The shares most recently traded at $154.22, up $0.12, or 0.08% since the insider transaction. Historical insider transactions for Chemed go as follows:

  • 4-Week # shares sold: 6,472
  • 12-Week # shares sold: 7,493
  • 24-Week # shares sold: 39,962

The average volume for Chemed has been 160,300 shares per day over the past 30 days. Chemed has a market cap of $2.6 billion and is part of the health care sector and health services industry. Shares are up 44.86% year-to-date as of the close of trading on Tuesday.

Chemed Corporation provides hospice and palliative care services in the United States. It operates in two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The stock currently has a dividend yield of 0.63%. The company has a P/E ratio of 24.3. Currently, there is 1 analyst who rates Chemed a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CHE - FREE

TheStreet Quant Ratings

rates Chemed as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and good cash flow from operations. We feel its strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Chemed Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.